Clinical Utility of a Novel Coronary Heart Disease Risk‐Assessment Test to Further Classify Intermediate‐Risk Patients

BACKGROUND: Current coronary heart disease (CHD) risk assessments inadequately assess intermediate‐risk patients, leaving many undertreated and vulnerable to heart attacks. A novel CHD risk‐assessment (CHDRA) tool was developed for intermediate‐risk stratification using biomarkers and established ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Solomon, Matthew D., Tirupsur, Ahalya, Hytopoulos, Evangelos, Beggs, Michael, Harrington, Douglas S., French, Cynthia, Quertermous, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2013
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231217/
https://www.ncbi.nlm.nih.gov/pubmed/23929798
http://dx.doi.org/10.1002/clc.22185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231217/
https://www.ncbi.nlm.nih.gov/pubmed/23929798
http://dx.doi.org/10.1002/clc.22185

Ejemplares similares